<DOC>
	<DOCNO>NCT01430299</DOCNO>
	<brief_summary>The objective study prospectively evaluate performance Integra Accell Evo3 Demineralized Bone Matrix adjunct posterolateral spine fusion retrospective comparison historical patient cohort .</brief_summary>
	<brief_title>Efficacy Safety Accell Evo3 DBM Instrumented Posterolateral Lumbar Spine Fusion</brief_title>
	<detailed_description />
	<mesh_term>Spondylosis</mesh_term>
	<criteria>Age 18 year age old time surgery Require spinal fusion use posterior TLIF , PLF PLIF 1 3 level L3S1 Followup radiographic image post surgery Long term user medication know inhibit fusion , bone metabolism epidural steroid injection Immunosuppressive agent , Disease Modifying Antirheumatic drug ( DMARDs ) similar immunomodulating drug , Growth Factors Insulin Treated radiotherapy since surgery Medical condition know impact bone metabolism , Paget 's disease , osteoporosis Pregnant lactate woman woman wish become pregnant Prisoner Participating investigational drug another device study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>